Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Evaluation of Emulsion Droplet Size Changes Over Time

Posted on By

SOP for Evaluation of Emulsion Droplet Size Changes Over Time

Evaluation of Emulsion Droplet Size Changes Over Time

1) Purpose

The purpose of this SOP is to outline the procedure for evaluating changes in emulsion droplet size over time. Monitoring droplet size distribution helps assess the stability of emulsions by identifying any signs of coalescence or instability during long-term storage.

2) Scope

This SOP applies to personnel involved in the quality control and stability testing of emulsions. It covers the preparation, sampling, and measurement of emulsion droplet size distribution using dynamic light scattering (DLS) or laser diffraction at specified intervals.

3) Responsibilities

  • Formulation Scientists: Responsible for preparing emulsion samples for droplet size analysis and ensuring accurate data collection.
  • QC Team: Responsible for conducting droplet size measurements and documenting the results during the stability study.
  • QA Team: Responsible for reviewing the data to ensure compliance with stability protocols and regulatory standards.
See also  SOP for Microbiological Stability Testing of Emulsions

4) Procedure

4.1 Sample Preparation

  • 4.1.1 Prepare emulsion formulations according to the batch manufacturing protocol.
  • 4.1.2 Store samples at the designated conditions (e.g., 25°C/60% RH, 30°C/65% RH) for stability testing.
  • 4.1.3 Label the samples with batch number, preparation date, and storage condition.

4.2 Instrument Calibration and Setup

  • 4.2.1 Calibrate the dynamic light scattering (DLS) instrument or laser diffraction device according to the manufacturer’s instructions.
  • 4.2.2 Set the
appropriate parameters for droplet size measurement, including scattering angle, temperature, and refractive index.

4.3 Droplet Size Measurement

The following steps outline the procedure for measuring emulsion droplet size distribution:

  • 4.3.1 Collect samples from the stored emulsions at each time point (e.g., 0 days, 1 month, 3 months, 6 months).
  • 4.3.2 Dilute the sample with deionized water or a suitable solvent if necessary to achieve the required concentration for analysis.
  • 4.3.3 Load the sample into the instrument and perform the droplet size measurement.
  • 4.3.4 Record the mean droplet size, polydispersity index (PDI), and droplet size distribution profile.

4.4 Data Recording and Analysis

  • 4.4.1 Record all test results in the Emulsion Droplet Size Distribution Report (see Annexure 1 for template).
  • 4.4.2 Compare the results over time to identify any changes in droplet size, which may indicate coalescence, aggregation, or instability.
  • 4.4.3 Analyze the data to assess the overall stability of the emulsion based on the droplet size distribution over time.

4.5 Acceptance Criteria

The emulsion formulation is considered stable if the following criteria are met:

  • 4.5.1 Mean droplet size remains within acceptable limits, with no significant increase or coalescence.
  • 4.5.2 The polydispersity index (PDI) remains below 0.3, indicating a narrow droplet size distribution and good stability.
  • 4.5.3 No significant changes in droplet size distribution profile that would indicate instability.

5) Abbreviations

  • DLS: Dynamic Light Scattering
  • PDI: Polydispersity Index
  • QC: Quality Control
  • QA: Quality Assurance

6) Documents

  • Emulsion Droplet Size Distribution Report
  • Batch Manufacturing Record (BMR)
  • Instrument Calibration Report

7) References

  • ICH Q1A: Stability Testing of New Drug Substances and Products
  • FDA Guidance on Emulsion-Based Drug Products

8) SOP Version

Version 1.0

Annexure

Annexure 1: Emulsion Droplet Size Distribution Report Template

Time Point Storage Condition Mean Droplet Size (nm) PDI Droplet Size Distribution Operator Initials
Initial 25°C/60% RH 100-300 nm 0.2 Uniform Operator Name
3 Months 30°C/65% RH 100-300 nm 0.2 Uniform Operator Name
See also  SOP for Use of Cholesterol in Liposome Formulations
Liposome and Emulsion Formulations Tags:Antioxidants in emulsions, API incorporation in emulsions, API incorporation in liposomes, Chemical stability testing liposomes, Cosmetic emulsion formulation, Emulsion droplet size analysis, Emulsion formulation SOP, Emulsion microbiological stability, Emulsion stability testing, Freeze-thaw stability testing, Heat-sensitive liposomes, High-shear mixing emulsions, Liposomal drug delivery SOP, Liposomal vaccines SOP, Liposome formulation SOP, Liposome particle size analysis, Liposome preparation procedure, Liposome size distribution, Liposome stability testing, Nanoemulsion SOP, Parenteral emulsion preparation, pH-responsive emulsions, Physical stability liposomes, Self-emulsifying drug delivery systems (SEDDS), Thin-film hydration liposomes

Post navigation

Previous Post: SOP for Routine Maintenance of GMP Equipment and Facilities
Next Post: SOP for Temperature and Humidity Monitoring in Production Areas

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version